Efficacy of artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated falciparum malaria in sub-Saharan Africa: An individual patient data meta analysis (IPDM) in 3,455 patients

Efficacy of artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated falciparum malaria in sub-Saharan Africa: An individual patient data meta analysis (IPDM) in 3,455 patients

Bibliographic Details
Main Authors:	Zwang, J, Olliaro, P, Nosten, F, Barennes, H, Brasseur, P, Dorsey, G, Guthmann, J, Martensson, A, D'Alessandr, U, Vaillant, M
Format:	Conference item
Published:	2007

Similar Items

EFFICACY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN NIMBA COUNTY, LIBERIA
by: Schramm, B, et al.
Published: (2010)

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data
by: Adjuik, M, et al.
Published: (2015)

A PHASE 4 RANDOMISED STUDY TO ASSESS THE TOLERABILITY OF ARTESUNATE-AMODIAQUINE (ASAQ) AND ARTEMETHER-LUMEFANTRINE (AL) FIXED DOSE COMBINATIONS (FDCS) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM (PF) MALARIA IN LIBERIA
by: Schramm, B, et al.
Published: (2010)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
by: Mwesigwa, J, et al.
Published: (2010)

POPULATION PHARMACOKINETICS OF ARTESUNATE AND AMODIAQUINE IN AFRICAN CHILDREN
by: Stepniewska, K, et al.
Published: (2008)

Population pharmacokinetics of artesunate and amodiaquine in African children.
by: Stepniewska, K, et al.
Published: (2009)

Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria.
by: Taylor, W, et al.
Published: (2006)

Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz
by: German, P, et al.
Published: (2007)

Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
by: German, P, et al.
Published: (2007)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
by: Walimbwa, S, et al.
Published: (2018)

Pengarah IPDM harumkan nama UUM
by: Berita, Harian
Published: (2016)

IPDM, RAPAT bantu keluarga miskin
by: Utusan, Malaysia (Utara)
Published: (2017)

IPDM, RAPAT bantu keluarga miskin
by: Utusan, Malaysia (Utara)
Published: (2017)

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership.
by: Lacaze, C, et al.
Published: (2011)

Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
by: Simpson, J, et al.
Published: (2006)

Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implications.
by: Graz, B, et al.
Published: (2010)

Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa
by: Zwang, J, et al.
Published: (2017)

The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data
by: Bretscher, MT, et al.
Published: (2020)

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia
by: Armedy, R, et al.
Published: (2006)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2011)

Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults
by: Banda, C, et al.
Published: (2018)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
by: Pasaribu, A, et al.
Published: (2013)

Pharmacokinetics of intravenous amodiaquine.
by: White, N, et al.
Published: (1987)

Can amodiaquine be resurrected?
by: White, N
Published: (1996)

Amodiaquine and malaria prophylaxis
by: Peto, T, et al.
Published: (1986)

The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
by: Chan, XHS, et al.
Published: (2021)

Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria.
by: Looareesuwan, S, et al.
Published: (1985)

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
by: Schramm, B, et al.
Published: (2013)

Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial.
by: Espié, E, et al.
Published: (2012)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
by: Nosten, F
Published: (2010)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia
by: Otienoburu, SD, et al.
Published: (2016)

Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa
by: Okell, L, et al.
Published: (2018)

Sensitivity To Amodiaquine Of Highly Chloroquine
by: Perpustakaan UGM, i-lib
Published: (1989)

Two patients with falciparum malaria and poor in vivo responses to artesunate.
by: Luxemburger, C, et al.
Published: (1998)

Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.
by: Zaloumis, S, et al.
Published: (2014)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
by: Maude, R, et al.
Published: (2009)

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
by: Hien, T, et al.
Published: (2004)

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
by: Venkatesan, M, et al.
Published: (2014)

Artesunate combinations for treatment of malaria: meta-analysis.
by: Adjuik, M, et al.
Published: (2004)